These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?]. Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249 [No Abstract] [Full Text] [Related]
3. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate. Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018 [TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis. Szanto E; Sandstedt B; Kollberg B Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206 [TBL] [Abstract][Full Text] [Related]
5. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going? Kremer JM J Rheumatol; 1992 Feb; 19(2):189-91. PubMed ID: 1629814 [No Abstract] [Full Text] [Related]
6. Longterm methotrexate therapy in rheumatoid arthritis: a review. Kremer JM J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773 [TBL] [Abstract][Full Text] [Related]
7. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio. Lanse SB; Arnold GL; Gowans JD; Kaplan MM Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate therapy in rheumatoid arthritis: 15 years experience. Hoffmeister RT Am J Med; 1983 Dec; 75(6A):69-73. PubMed ID: 6660241 [TBL] [Abstract][Full Text] [Related]
10. Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al. Newman ED; Harrington TM; Perruquet JL; Davis DE; Torretti D Arthritis Rheum; 1995 Feb; 38(2):297-8. PubMed ID: 7848325 [No Abstract] [Full Text] [Related]
14. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines? Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Erickson AR; Reddy V; Vogelgesang SA; West SG Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808 [TBL] [Abstract][Full Text] [Related]
16. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective. Lewis JH J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133 [No Abstract] [Full Text] [Related]
18. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis. Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779 [TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity of methotrexate in the treatment of psoriasis. Palmer HM Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241 [No Abstract] [Full Text] [Related]
20. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities. Yazici Y; Erkan D; Harrison MJ; Nikolov NP; Paget SA Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]